This correction concerns an article on the synergistic interactions of melatonin and glucocorticoids in attenuating the allergic airway inflammatory response. The study included a clinical case-control study to assess asthma control scores, biochemical markers, exhaled nitric oxide (FeNO) and sleep quality. Clinical results showed significant correlations between asthma control scores, melatonin and PSQI sleep quality, suggesting an important role for melatonin in asthma control[1]. In experiments on animal models, melatonin reduced the allergic inflammatory response of the airways and stabilized the expression of circadian rhythm genes[1]. The combination of melatonin with glucocorticoids, such as dexamethasone, showed a significantly enhanced effect on reducing the allergic inflammatory response of the airways[1]. Glucocorticoids form the mainstay of asthma treatment, and the anti-inflammatory properties of melatonin may improve their effectiveness through circadian rhythm regulation[1].